Watson is use at our clinical sites for sample collection and management. It is also use in our bioanalytical Ligand binding and small/large molecule laboratories. Our preclinical site is currently implementing the software. Our bioanalytical lab also use Watson for their reporting.
Globally, the system is not very well suited. Lack of appropriate interfaces for instrument detectors is a good example. Watson lims can maintain sample traceability correctly however, it is clearly not designed for high throughput sample analysis. Our laboratory global efficiency significantly decreased upon Watson Lims implementation. New ''Analytical samples'' functionality was now well designed and have a lot of limitations. The Software validation provided and executed by the vendor is weak and showed major execution error also with poor documentation practice. Very disappointing.
The only positive impact is for client facing. Watson lims is well known in the industry and the purchase of this software increase the credibility of our organization.
The ROI is a disaster. First: The cost of the software is significantly to high, the user licences cost also contribute in the ROI disaster. Second: The implementation of watson lims significantly decrease our laboratory efficiency.